Supernus Pharmaceuticals SUPN
$ 34.67
2.06%
Quarterly report 2024-Q3
added 11-04-2024
Country |
USA |
IPO year |
2012 |
Industry |
Drug manufacturers |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Mr. Jack Khattar |
Employees in the company |
464 |
Shares |
53.7 M |
Market Cap[1] |
$ 1.86 B |
EBITDA (LTM) |
$ 90.9 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.